
The risk of cancer increases with age, and as the zzso population rapidly ages, the number of older adults seeking treatment for cancer is also increasing zzso However, this growing population of older adults has been underrepresented in clinical trials that set the standards for zzso zzso In addition, most clinical trials conducted to date have not addressed the problems that accompany aging, including reduced zzso reserve, changes in drug zzso and the impact of zzso medical conditions and zzso on treatment zzso As a result, there are variations in treatment patterns between older and younger adults and few evidence-based guidelines accounting for the changes in physiology or zzso that occur with zzso This article examines the demographics of cancer and aging, the barriers to enrollment of older adults on clinical trials, and approaches for future trials to address the needs of the older zzso 

